id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2001-D-0219-0002,FDA,FDA-2001-D-0219,Draft Guidance for Clinical Trial Sponsors on the Establishment and Operation of Clinical Trial Data Monitoring Committees; Availability,Notice,NAD-Notice of Availability of Data,2001-11-20T05:00:00Z,2001,11,2001-11-19T05:00:00Z,2002-02-20T04:59:59Z,2010-05-10T16:34:55Z,,0,0,09000064804e4e02
FDA-2001-D-0219-0001,FDA,FDA-2001-D-0219,Draft FDA Guidance on the Estabtishment and Operation of Clinical Trial Data Monitoring Committees; Public Meeting,Notice,NM-Notice of Meeting,2001-11-05T05:00:00Z,2001,11,,,2010-05-10T16:33:19Z,,0,0,09000064804e4d7b